Aster DM Healthcare Q4 FY26 Highlights

📊 Aster DM Healthcare Q4 FY26 Highlights Revenue: ₹11.8B vs ₹10B YoY (+18%) EBITDA: ₹2.3B vs ₹1.92B YoY (+20%) EBITDA Margin: 19.65% vs 19.2% YoY (slight improvement) Net Profit: ₹1.4B vs ₹790.2M YoY (+77%) 📈 Fundamentals Business Model: Operates hospitals, clinics, and pharmacies across India and GCC countries. Growth Drivers: Rising healthcare demand in India and Middle East. Expansion of hospital network and specialty services. Increasing medical tourism and higher-margin procedures. Strengths: Strong presence in GCC markets with stable cash flows. Improving margins through operational efficiency. Diversified revenue streams (hospitals, clinics, pharmacies). 📊 Key Financial Ratios (FY26 Estimates) Metric Value Context P/E Ratio ~28–30x Reasonable vs healthcare peers (Apollo Hospitals ~45x) RoE ~16–17% Improving with profit growth RoCE ~18–19% Healthy capital efficiency Debt/Equity ~0.4 Moderate leverage, manageable EBITDA Margin ~19.6% Stable, slightly improving YoY Dividend Yield ~1% Lower, reinvesting for growth Strong revenue and profit growth, margin expansion, robust GCC operations. Neutral/Concern: Moderate leverage, competitive healthcare sector, dependency on GCC markets.